Company Filing History:
Years Active: 2010
Title: Arnaud Scherberich: Innovator in Biomedical Research
Introduction
Arnaud Scherberich is a notable inventor based in Riedisheim, France. He has made significant contributions to the field of biomedical research, particularly in the study of extracellular matrix molecules. His work focuses on innovative solutions for cancer treatment and bone regeneration.
Latest Patents
Scherberich holds a patent for "Tenascin-W compositions and uses thereof." This patent involves Tenascin-W, an extracellular matrix molecule that is specifically expressed in metastatic tumors. The invention provides a system that utilizes a sample expressing Tenascin-W as an in vitro method for screening potential anti-tumor agents or agents that promote osteogenesis. This advancement has the potential to impact cancer therapies and regenerative medicine.
Career Highlights
Arnaud Scherberich is associated with the Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research. His role at this prestigious institution allows him to collaborate with leading scientists and contribute to groundbreaking research in the biomedical field.
Collaborations
Scherberich has worked alongside Ruth Chiquet-Ehrismann, a prominent figure in the field. Their collaboration has likely fostered innovative research and development in the study of extracellular matrix components.
Conclusion
Arnaud Scherberich's contributions to biomedical research, particularly through his patent on Tenascin-W, highlight his role as an innovator in the field. His work continues to pave the way for advancements in cancer treatment and regenerative medicine.